Viewing Study NCT00075634


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-03-05 @ 4:40 PM
Study NCT ID: NCT00075634
Status: COMPLETED
Last Update Posted: 2013-09-30
First Post: 2004-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Neuroblastoma View
None Unspecified Childhood Solid Tumor, Protocol Specific View
Keywords: